ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,270.00
      -0.33%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.135
      -0.25%
      Bitcoin
      63,253.82
      0.48%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      09/18/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/18/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/17/20244:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/17/20243:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/17/20243:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/05/20248:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming 2024 Cantor Global Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      09/03/20248:00AMGlobeNewswire Inc.Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)NASDAQ:ESPREsperion Therapeutics Inc
      08/26/20248:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      08/20/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      08/19/20243:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      08/12/20244:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ESPREsperion Therapeutics Inc
      08/12/20244:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ESPREsperion Therapeutics Inc
      08/12/20247:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ESPREsperion Therapeutics Inc
      08/12/20246:00AMGlobeNewswire Inc.Esperion Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ESPREsperion Therapeutics Inc
      08/12/20245:47AMIH Market NewsU.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices ClimbNASDAQ:ESPREsperion Therapeutics Inc
      08/07/20244:30PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/05/20244:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ESPREsperion Therapeutics Inc
      07/25/20248:00AMGlobeNewswire Inc.Esperion to Report Second Quarter 2024 Financial Results on August 12NASDAQ:ESPREsperion Therapeutics Inc
      07/24/20248:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming BTIG Biotech ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      07/19/20248:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/19/20248:29AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/17/20243:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/17/20243:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/16/20248:00AMGlobeNewswire Inc.New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their ArteriesNASDAQ:ESPREsperion Therapeutics Inc
      06/28/20247:00AMGlobeNewswire Inc.Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest FacilityNASDAQ:ESPREsperion Therapeutics Inc
      06/18/20243:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      06/18/20243:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      05/28/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ESPREsperion Therapeutics Inc
      05/24/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      05/24/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR